logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure INF-11. Notified cases of hepatitis B in injecting drug users: proportion injecting drug users among hepatitis B notifications with risk factor information, 2001 to 2005


Data for England and Wales are not national level.

Data are laboratory reports and not notifications A = acute cases; AC = acute and chronic cases; C = chronic cases

1 - Estonia: Number of notified cases among IDUs in 2004 are 48.


SB2006: Figure INF-12 part (i)

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Reitox national focal points.

For primary sources and study details, see Table INF-6 and Table INF-0.

Page last updated: Wednesday, 21 November 2007